Status:
RECRUITING
The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
Clostridium Butyricum Miyairi
Parkinson Disease
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
Detailed Description
The physician will explain the trial procedures in the outpatient, and then obtain the written informed consent to start the interview. And randomly divided into experimental and observation groups, a...
Eligibility Criteria
Inclusion
- Male or female over 20 years old, diagnosed with Parkinson's disease.
Exclusion
- People with Parkinson's disease Dementia, or Lactose Intolerance
Key Trial Info
Start Date :
October 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06548256
Start Date
October 31 2023
End Date
December 31 2026
Last Update
August 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical Univeristy Hospital
Kaohsiung City, Taiwan